Cambridge Investment Research Advisors Inc. increased its stake in Encompass Health Co. (NYSE:EHC – Get Rating) by 66.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,279 shares of the company’s stock after purchasing an additional 3,319 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Encompass Health were worth $495,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in EHC. Baupost Group LLC MA lifted its position in Encompass Health by 318.9% during the 1st quarter. Baupost Group LLC MA now owns 3,000,000 shares of the company’s stock worth $213,330,000 after buying an additional 2,283,900 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in shares of Encompass Health during the 3rd quarter worth approximately $51,692,000. Brown Advisory Inc. grew its position in shares of Encompass Health by 25.3% during the 3rd quarter. Brown Advisory Inc. now owns 1,547,087 shares of the company’s stock worth $69,975,000 after purchasing an additional 312,753 shares in the last quarter. Bernzott Capital Advisors acquired a new position in shares of Encompass Health during the 3rd quarter worth approximately $12,148,000. Finally, Renaissance Technologies LLC boosted its position in shares of Encompass Health by 425.2% during the 3rd quarter. Renaissance Technologies LLC now owns 320,900 shares of the company’s stock worth $14,514,000 after acquiring an additional 259,800 shares in the last quarter. 96.14% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the stock. Barclays raised their target price on shares of Encompass Health from $57.00 to $61.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 4th. Stephens reissued an “overweight” rating and set a $70.00 target price on shares of Encompass Health in a research note on Wednesday, February 8th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Encompass Health from $70.00 to $73.00 in a research note on Monday, May 1st. Credit Suisse Group raised their price target on shares of Encompass Health from $62.00 to $73.00 and gave the stock an “outperform” rating in a report on Thursday, February 9th. Finally, UBS Group raised their price target on shares of Encompass Health from $68.00 to $73.00 in a report on Wednesday, February 8th. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Encompass Health presently has an average rating of “Buy” and a consensus price target of $70.91.
Encompass Health Stock Down 0.6 %
Encompass Health (NYSE:EHC – Get Rating) last released its earnings results on Friday, April 28th. The company reported $0.88 earnings per share for the quarter, beating analysts’ consensus estimates of $0.70 by $0.18. The firm had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.14 billion. Encompass Health had a net margin of 5.75% and a return on equity of 16.80%. The company’s revenue was down 13.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.97 EPS. As a group, equities analysts predict that Encompass Health Co. will post 3.15 EPS for the current year.
Encompass Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, July 17th. Investors of record on Monday, July 3rd will be issued a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 1.00%. The ex-dividend date of this dividend is Friday, June 30th. Encompass Health’s dividend payout ratio is currently 22.22%.
About Encompass Health
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.
- Get a free copy of the StockNews.com research report on Encompass Health (EHC)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC – Get Rating).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.